Rachid Benhida

Dr. Rachid Benhida


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in Cancer Cell
Verified
Journal Article
Closed access
MCMichael CEREZO
Michael CEREZO
ALAbdelali Lehraiki
Abdelali Lehraiki
AMAntoine Millet
Antoine Millet
FRFlorian Rouaud
Florian Rouaud
MPMagali Plaisant
Magali Plaisant
SRStephane Rocchi
Stephane Rocchi

29 August 2016 in Medicinal Research Reviews
Verified
Journal Article
Closed access
PDF file
AMAntoine Millet
Antoine Millet
AMAnthony R. Martin
Anthony R. Martin
CRCyril Ronco
Cyril Ronco
SRStephane Rocchi
Stephane Rocchi
RBRachid Benhida
Rachid Benhida

30 November 2016 in MedChemComm
Verified
Journal Article
Closed access
PDF file
CRCyril Ronco
Cyril Ronco
AMAnthony R. Martin
Anthony R. Martin
LDLuc Demange
Luc Demange
RBRachid Benhida
Rachid Benhida
A review highlighting on cancer stem cells, with an exhaustive listing and comparison of biological efficacies and pharmacology of the inhibitors of 5 pivotal enzymes of the DNA-damage response.

10 August 2022 in Molecules
Verified
Journal Article
Open access
PDF file
MFMarie Fabre
Marie Fabre
LMLou Mateo
Lou Mateo
DLDiana Lamaa
Diana Lamaa
Stéphanie BAILLIFStéphanie BAILLIF
Stéphanie BAILLIF
Gilles PagèsGilles Pagès
Gilles Pagès
RBRachid Benhida
Rachid Benhida
Age-related macular degeneration (AMD) was described for the first time in the 1840s and is currently the leading cause of blindness for patients over 65 years in Western Countries. This disease impacts the eye’s posterior segment and damages the macula, a retina section with high levels of photoreceptor cells and responsible for the central vision. Advanced AMD stages are divided into the atrophic (dry) form and the exudative (wet) form. Atrophic AMD consists in the progressive atrophy of the retinal pigment epithelium (RPE) and the outer retinal layers, while the exudative form results in the anarchic invasion by choroidal neo-vessels of RPE and the retina. This invasion is responsible for fluid accumulation in the intra/sub-retinal spaces and for a progressive dysfunction of the photoreceptor cells. To date, the few existing anti-AMD therapies may only delay or suspend its progression, without providing cure to patients. However, in the last decade, an outstanding number of research programs targeting its different aspects have been initiated by academics and industrials. This review aims to bring together the most recent advances and insights into the mechanisms underlying AMD pathogenicity and disease evolution, and to highlight the current hypotheses towards the development of new treatments, i.e., symptomatic vs. curative. The therapeutic options and drugs proposed to tackle these mechanisms are analyzed and critically compared. A particular emphasis has been given to the therapeutic agents currently tested in clinical trials, whose results have been carefully collected and discussed whenever possible.

1 November 2020 in Bioorganic Chemistry
Verified
Journal Article
Closed access
OGOleksandr Grytsai
Oleksandr Grytsai
OVOksana Valiashko
Oksana Valiashko
MPManon Penco-Campillo
Manon Penco-Campillo
MDMaeva Dufies
Maeva Dufies
AHAnais Hagege
Anais Hagege
RBRachid Benhida
Rachid Benhida

3 November 2010 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
VMVincent Malnuit
Vincent Malnuit
MDMaria Duca
Maria Duca
RBRachid Benhida
Rachid Benhida
This review, divided into three sections, describes the contribution of the chemists’ community to the development and application of triple helix strategy by using artificial nucleic acids, particularly for the recognition of DNA sequences incorporating base pair inversions. Firstly, the development of nucleobases that recognise CG inversion is surveyed followed secondly by specific recognition of TA inverted base pair. Finally, we point out in the last section recent perspectives and applications, driven from knowledge in nucleic acids interactions, in the growing field of nanotechnology and supramolecular chemistry at the border area of physics, chemistry and molecular biology.